SENSEX NIFTY

Us Manufacturing Ism

Sep 24, 2016 at 09:54 | Source: PTI
The missiles will be manufactured at several places in the United States, with the majority of them being in St Charles, Missouri. Some manufacturing process would also be done in the United Kingdom.
Sep 22, 2016 at 20:44 | Source: PTI
The company plans to invest Rs 50 crore to start manufacturing of engines, which are currently assembled from imported parts from different markets across the globe, as part of its plans to fully localise its motorcycles in the next 12-18 months.
Sep 22, 2016 at 13:34 | Source: PTI
In a BSE filing, Aurobindo Pharma said it has received "tentative approval for Dolutegravir 50 mg from US Food & Drug Administration (USFDA) for the treatment of HIV.
Sep 21, 2016 at 17:38 | Source: PTI
Amerisource Health Services is recalling 2,626 bottles of Bupropion Hydrochloride extended-release tablets USP (XL), 300 mg manufactured by Ahemdabad based Cadila Healthcare.
Sep 16, 2016 at 15:12 | Source: Moneycontrol.com
"Themis and Nevakar LLC has signed an agreement to develop injectable products that will be further developed, manufactured and commercialised by Nevakar in the US & select global markets," the pharma company said in its filing.
Sep 16, 2016 at 14:04 | Source: PTI
"Under the agreement Themis will develop a selected number of innovative, differentiated injectable products that will be further developed, manufactured and commercialised by Nevakar in the US and select global markets," Themis Medicare said in a filing to BSE.
Sep 16, 2016 at 08:35 | Source: CNBC-TV18
According to Geoff Lewis of Manulife Asset Management, risk-reward ratio is in favour of emerging markets (EMs) against developed markets. Among the developing nations, he prefers manufacturing based markets over commodity producers of Latin America and US equities over European, in the developed markets, he added.
Sep 07, 2016 at 19:38 | Source: PTI
In a warning letter to Pan Drugs MD and Chairman Kamal Pandya, US Food and Drug Administration (USFDA) said the company's "methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, your drug products are adulterated within the meaning of the Federal Food, Drug, and Cosmetic Act..."
Sep 06, 2016 at 13:26 | Source: CNBC-TV18
Speaking to CNBC-TV18, Sanjay Nayar, CEO of KKR India said that manufacturing is the exciting segment now. With operational ease in India, manufacturing has to remain top priority for us, he said.
Sep 02, 2016 at 11:55 | Source: Moneycontrol.com
According to Achiievers Equities,Silver gained as prices remained supported after data showing a fall in U.S. manufacturing activity pressured the dollar.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.